Nongenetic risk factors for holoprosencephaly: An updated review of the epidemiologic literature

American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
April D SummersSonja A Rasmussen

Abstract

Holoprosencephaly (HPE) is a major structural birth defect of the brain that occurs in approximately 1 in 10,000 live births. Although some genetic causes of HPE are known, a substantial proportion of cases have an unknown etiology. Due to the low birth prevalence and rarity of exposure to many potential risk factors for HPE, few epidemiologic studies have had sufficient sample size to examine risk factors. A 2010 review of the literature identified several risk factors that had been consistently identified as occurring more frequently among cases of HPE, including maternal diabetes, twinning, and a predominance of females, while also identifying a number of potential risk factors that had been less widely studied. In this article, we summarize a systematic literature review conducted to update the evidence for nongenetic risk factors for HPE.

References

Jan 1, 1992·Journal of Medical Genetics·B KällénE Robert
Jan 1, 1990·Fetal Diagnosis and Therapy·S M BerryK H Nicolaides
Sep 1, 1987·American Journal of Medical Genetics·L SuslakF Desposito
Jun 1, 1982·The American Journal of Cardiology·R J Moene, A Oppenheimer-Dekker
Jul 1, 1996·Journal of Medical Genetics·M L Whiteford, J L Tolmie
Dec 18, 1996·American Journal of Medical Genetics·S A RasmussenJ F Cordero
Dec 31, 1997·American Journal of Medical Genetics·C L OlsenM Sharpe-Stimac
Jul 23, 1998·American Journal of Medical Genetics·M L Martínez-FríasJ L Frías
May 12, 2001·American Journal of Obstetrics and Gynecology·P J BullenS C Robson
Mar 13, 2002·Public Health Reports·P W YoonL D Edmonds
Jun 12, 2003·Birth Defects Research. Part A, Clinical and Molecular Teratology·Sonja A RasmussenUNKNOWN National Birth Defects Prevention Study
Jan 28, 2004·Birth Defects Research. Part A, Clinical and Molecular Teratology·Anthony R ScialliMelissa S Tassinari
Dec 23, 2004·Epidemiology·James L AndersonMartha M Werler
Nov 8, 2007·American Journal of Medical Genetics. Part a·Iêda M Orioli, Eduardo E Castilla
Nov 16, 2007·American Journal of Medical Genetics. Part a·Sonja A RasmussenDaniel R O'Leary
Aug 5, 2008·American Journal of Obstetrics and Gynecology·Adolfo CorreaE Albert Reece
Feb 14, 2009·Birth Defects Research. Part A, Clinical and Molecular Teratology·Marilyn L BrowneUNKNOWN National Birth Defects Prevention Study
Nov 4, 2009·Archives of Pediatrics & Adolescent Medicine·Krista S CriderDale J Hu
Jan 28, 2010·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Erich Roessler, Maximilian Muenke
Jan 28, 2010·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Eric A MillerUNKNOWN National Birth Defects Prevention Study
Jan 28, 2010·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Candice Y Johnson, Sonja A Rasmussen
Jan 28, 2010·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Iêda M Orioli, Eduardo E Castilla
Jan 28, 2010·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Jin S Hahn, Patrick D Barnes
Jul 29, 2010·Seminars in Fetal & Neonatal Medicine·Martin A Weber, Neil J Sebire
Feb 15, 2011·Birth Defects Research. Part A, Clinical and Molecular Teratology·Tonia C CarterUNKNOWN National Birth Defects Prevention Study
Oct 12, 2011·Birth Defects Research. Part A, Clinical and Molecular Teratology·Peter W G TennantJudith Rankin
Oct 19, 2011·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Iêda M OrioliEduardo E Castilla
Jan 31, 2012·American Journal of Obstetrics and Gynecology·Adolfo CorreaUNKNOWN National Birth Defects Prevention Study
Mar 16, 2012·American Journal of Medical Genetics. Part a·Simone S VazAsuri N Prasad
Jul 24, 2012·Birth Defects Research. Part A, Clinical and Molecular Teratology·Simerpal K GillUNKNOWN National Birth Defects Prevention Study
Jul 24, 2012·Birth Defects Research. Part A, Clinical and Molecular Teratology·Sivithee SrisukhumbowornchaiMarcia L Feldkamp
Nov 23, 2012·American Journal of Epidemiology·Samantha E ParkerUNKNOWN National Birth Defects Prevention Study
Jan 2, 2013·Taiwanese Journal of Obstetrics & Gynecology·Chih-Ping ChenWayseen Wang
Feb 14, 2014·Birth Defects Research. Part A, Clinical and Molecular Teratology·Rachel SokalKate M Fleming
Apr 20, 2014·Frontiers in Endocrinology·Amy C Schroeder, Martin L Privalsky
Feb 26, 2015·American Journal of Medical Genetics. Part a·Adrian M MichalskiCharlotte M Druschel
Mar 19, 2015·Birth Defects Research. Part C, Embryo Today : Reviews·Asher OrnoyRichard Kermit Miller
Apr 22, 2015·World Journal of Diabetes·Rinat Gabbay-BenzivPeixin Yang
Jun 3, 2015·Birth Defects Research. Part A, Clinical and Molecular Teratology·Jennita ReefhuisUNKNOWN National Birth Defects Prevention Study
Dec 29, 2015·Neurotoxicology and Teratology·Marcoita T GilbertScott E Parnell
Jun 22, 2016·Journal of Epidemiology and Community Health·April L DawsonUNKNOWN National Birth Defects Prevention Study
Oct 30, 2016·American Journal of Obstetrics and Gynecology·Adrienne T HoytMarcia L Feldkamp
Nov 29, 2016·Birth Defects Research. Part A, Clinical and Molecular Teratology·Meredith M HowleyUNKNOWN National Birth Defects Prevention Study
Apr 26, 2017·PloS One·Mingi Hong, Robert S Krauss
Aug 2, 2017·Birth Defects Research·Meredith M HowleyUNKNOWN National Birth Defects Prevention Study

❮ Previous
Next ❯

Citations

Jun 10, 2020·Environmental Health : a Global Access Science Source·Yonit A AddissieMaximilian Muenke
Oct 29, 2020·Birth Defects Research·Yonit A AddissiePaul Kruszka

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
Candice Y Johnson, Sonja A Rasmussen
The Journal of Clinical Investigation
Xin Geng, Guillermo Oliver
Orthodontics & Craniofacial Research
S A Boyadjiev, International Craniosynostosis Consortium
© 2022 Meta ULC. All rights reserved